Statistical Comparison of Carcinogenic Effects and Dose-Response Relationships in Rats and Mice for 2,4-Toluene Diamine to those Ascribed to Toluene Diisocyanate

Human and Ecological Risk Assessment

Volumn 18, Issue 6, 2012, Pages 1315-1337

  Sielken, Robert L ^a   Bretzlaff, Robert S ^a   Valdez Flores, Ciriaco ^a   Parod, Ralph ^b  

^a Sielken & Associates Inc   (United States)

^b BASF CORPORATION   (United States)

Author keywords

atypical (gavage) exposure conditions; flawed test substance handling and storage conditions; hydrolyze TDI to TDA; toluene diamine (TDA); toluene diisocyanate (TDI); tumorigenic responses in rats and mice

Indexed keywords

EID: 84869197869     PISSN: 10807039     EISSN: 15497860     Source Type: Journal    
DOI: 10.1080/10807039.2012.722853     Document Type: Article

References (31)

1. Austin, S. 2007. Biological monitoring of TDI-derived amines in polyurethane foam production. Occup Med, 57(6): 444-8.
2. Brorson, T, Skarping, G and Sangö, C. 1991. Biological monitoring of isocyanates and related amines. IV. 2,4- and 2,6-toluenediamine in hydrolysed plasma and urine after test-chamber exposure of humans to 2,4- and 2,6-toluene diisocyanate. Internat Arch Occup Environ Health, 63(4): 253-9.
3. Cheung, Y-L, Snelling, JMohammed, N ND. 1996. Interaction with the aromatic hydrocarbon receptor, CYP1A induction, and mutagenicity of a series of diaminotoluenes: Implications for their carcinogenicity. Toxicol Appl Pharmacol, 139: 203-11.
4. Cunningham, M L, Foley, JMaronpot, R R. 1991. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair- 2,6- and 2,4-diaminotoluene. Toxicol Appl Pharmacol, 107: 562-7.
5. Dieter, M P, Boorman, G AJameson, C W. 1990. The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-TDI isomers. Toxicol Ind Health, 6(6): 599-621.
6. Hagmar, L, Welinder, H and Mikoczy, Z. 1993a. Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry. Brit J Ind Med, 50: 537-43.
7. Hagmar, L, Stromberg, UWelinder, H. 1993b. Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyldiisocyanate: A cohort based case referent study in the polyurethane foam manufacturing industry. Brit J Ind Med, 50: 1003-7.
8. IARC (International Agency for Research on Cancer). 1986. "Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans". In Some Chemicals Used in Plastics and Elastomers Vol. 39, 287-323. Lyon, France
9. Jeffcoat, AR. 1988. Absorption and Disposition of Orally Administered 2,4-Toluene Diisocyanate in the Fischer 344 Rat, Research Triangle Park, NC, USA: Research Triangle Institute. RTI report (RTI/3662/02P) for NIEHS (NO1-ES-65137)
10. Kaaria, K, Hirvonen, ANorppa, H. 2001. Exposure to 2,4- and 2,6-toluene diisocyanate (TDI) during production of flexible foam: Determination of airborne TDI and urinary 2,4- and 2,6-toluenediamine (TDA). Analyst, 126: 1025-31.
11. Kennedy, A L and Brown, W E. 1999. Investigation of the Chemistry of TDI in Biological Materials, Parsippany, NJ, USA: International Isocyanate Institute, Inc. III Report No. 11320
12. Löser, E. 1983. Long-term toxicity and carcinogenicity studies with 2,4/2,6-TDI (80/20) in rats and mice. Toxicol Letters, 15: 71-81.
13. Mikoczy, Z, Welinder, HTinnerberg, H. 2004. Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: Updated findings 1959-98. Occup Environ Med, 61: 432-37.
14. NTP (National Toxicology Program). 1979. Bioassay of 2,4-Diaminotoluene for Possible Carcinogenicity (CAS No. 95-80-7), 79-1718. Bethesda, MD, USA: National Institutes of Health. Technical report No. 162. NIH Publication No
15. NTP. 1980. Bioassay of 2,6-Diaminotoluene Dihydrochloride for Possible Carcinogenicity (CAS No. 15481-70-6), 80-20. Bethesda, MD, USA: National Institutes of Health. Technical report No. 200.NIH Publication No
16. NTP. 1986. Toxicology and Carcinogenesis Studies of Commercial Grade 2,4 (80%)-and 2,6 (20%)-Toluene Diisocyanate (CAS No, 86-2507. Bethesda, MD, USA: National Institutes of Health. 26471-62-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical report No. 251. NIH Publication No
17. NTP. 2005. Report on Carcinogens, 11th edit, Washington, DC, USA: US Department of Health and Human Services, Public Health Service.
18. Owen, P. 1984. The Toxicity and Carcinogenicity to Rats of Toluene Diisocyanate Vapour Administered by Inhalation for a Period of 113 Weeks, Parsippany, NJ, USA: (Harrogate, England) for the International Isocyanate Institute. Addendum Report Volume 1. Hazelton Laboratories Europe Ltd
19. Persson, P, Dalene, MSkarping, G. 1993. Biological monitoring of occupational exposure to toluene diisocyanate: Measurement of toluenediamine in hydrolysed urine and plasma by gas chromatography-mass spectrometry. Br J Ind Med, 50(12): 1111-8.
20. Rosenberg, C and Savolainen, H. 1985. Detection of urinary amine metabolites in toluene diisocyanate exposed rats. J Chromatogr, 323(2): 429-33.
21. Schnorr, T, Steenland, KEgeland, G. 1996. Mortality of workers exposed to toluenedisocanate in the polyurethane foam industry. Occup Environ Med, 53: 703-7.
22. Seel, K, Walber, UHerbold, B. 1999. Chemical behavior of seven aromatic diisocyanates (toluenediisocyanates and diphenylmethanediisocyanates) under in vitro conditions in relationship to their results in the Salmonella/microsome test. Mut Res, 438: 109-23.
23. Sennbro, C J, Lindh, C HTinnerberg, H. 2003. Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4- and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate. Biomarkers, 8(3-4): 204-17.
24. Shiotsuka, RN. 1987. "Sensory Irritation Study of Mondur TD-80 in Sprague-Dawley Rats". In Mobay Corporation, Corporate Toxicology Department, Pittsburgh, PA, USA: now Bayer MaterialScience LLC. Study No. 86-341-02. Report No. 842. Mobay Corp.
25. Skarping, G, Dalene, M and Lind, P. 1994. Determination of toluenediamine isomers by capillary gas chromatography and chemical ionization mass spectrometry with special reference to the biological monitoring of 2,4- and 2,6-toluene diisocyanate. J Chromotography, 663: 199-210.
26. Sorahan, T and Nichols, L. 2002. Mortality and cancer morbidity of production workers in the UK flexible polyurethane foam industry: Updated findings 1958-98. Occup Environ Med, 59: 751-8.
27. Sorahan, T and Pope, D. 1993. Mortality and cancer morbidity of production workers in the United Kingdom flexible polyurethane foam industry. Brit J Ind Med, 50: 528-36.
28. Timchalk, C, Smith, F A and Bartels, M J. 1994. Route-dependent comparative metabolism off [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats. Toxicol Appl Pharmacol, 124(2): 181-90.
29. USEPA (US Environmental Protection Agency). 1988. "Methodology for Evaluating Potential Carcinogenicity in Support of Reportable Quantity Adjustments Pursuant to CERCLA Section 102. OHEA-C-073". Washington, DC, USA: Carcinogen Assessment Group, Office of Health and Environmental Assessment. EPA-600/8-89-053
30. USEPA. 2005. "Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F". In Risk Assessment Forum Washington, DC, USA
31. Zeiger, E, Anderson, BHaworth, S. 1987. Salmonella mutagenicity tests: III. Results from testing of 255 chemicals. Environ Mutagen, 9(Suppl 9): 1-110.